Chapter 8B – Primary Amenorrhea in Pediatric and Adolescent Gynecology Practice




Chapter 8B Primary Amenorrhea in Pediatric and Adolescent Gynecology Practice Endocrine Causes of Primary Amenorrhea


Adam Balen and Gerard S. Conway



Introduction


The endocrine causes of primary amenorrhea may result from abnormalities in the development of the ovaries, a disturbance of the normal endocrinological events of puberty or of the hypothalamic-pituitary-ovarian axis. Overall it is estimated that endocrine disorders account for approximately 25 percent of cases of primary amenorrhea [1,2].


The failure to menstruate by age 16 in the presence of normal secondary sexual development, or age 14 in the absence of secondary sexual characteristics warrants investigation. This distinction helps differentiate reproductive tract anomalies from gonadal quiescence and gonadal failure. Or in other words, to differentiate between estrogen replete and estrogen deficient states. A listing of the causes of primary amenorrhea is shown in Table 8B.1.




Table 8B.1 Endocrine Causes of Primary Amenorrhea




























































Hypothalamic disorders Constitutional delay of puberty
Stress, exercise, weight related
Amenorrhea, chronic illness
Idiopathic hypogonadotrophic hypogonadism (IHH)
Kallmann’s syndrome
Tumors (craniopharyngiomas, gliomas, germinomas, dermoid cysts)
Cranial irradiation, head injuries (rare in young girls)
Disorders of anterior pituitary function Pituitary adenomas
Hypopituitarism
Hyperprolactinaemia
Hypothyroidism
Disorders of the ovary Gonadal agenesis/dysgenesis,
including Turner’s syndrome
Premature ovarian insufficiency
(genetic, autoimmune,
infective, radio/chemotherapy)
Polycystic ovary syndrome
(PCOS)

Secondary amenorrhea is the absence of menstruation of more than 6 months duration and may be temporary or permanent. Any cause of secondary amenorrhea may also cause primary amenorrhea. For example, weight loss, polycystic ovary syndrome (PCOS), and pregnancy may present with either primary or secondary amenorrhea.



Endocrine Determinants of Age of Menarche


The age of menarche is determined by general health and genetic, socioeconomic, and nutritional factors. The menstrual cycle involves the coordination of a series of events by the hypothalamic-pituitary-ovarian axis and is influenced by physiological, pathological, and psychological changes.


Nutrition and body weight play an important role in pubertal development. Chronic disease, malnutrition, eating disorders, and high levels of physical activity may delay menarche because of suppression or the hypothalamic pulse generator secreting GnRH. The mechanism for this relationship is complex with the leptin, kisspeptin, neurotransmitter neuropeptide Y (NPY) pathway being the most important [3]. Leptin, secreted from white fat cells signals satiety by suppressing the activity of the central NPY, as well as stimulating appetite and eating behavior, controls GnRH activity (and therefore reproduction) as well as adrenocorticotropic hormone (ACTH) and thyroid stimulating hormone (TSH) secretion (so modifying metabolism and the response to stress). Leptin levels are low in starvation, resulting in heightened NPY activity, elevated ACTH and cortisol concentrations, and low TSH and thyroxine concentrations – as typically seen in patients with severe anorexia nervosa. As weight is regained, leptin secretion resumes, NPY activity falls, and GnRH secretion resumes, thus permitting the return of fertility as nutrition returns to normal. It is thought that leptin also plays an important role in the initiation of puberty, along with other hormones that are involved in the regulation of GnRH secretion such as kisspeptin. This may explain the key relationships between body fat and pubertal maturation observed by Frisch and Revelle [4].


Insulin has also been suggested as a modulator of the tempo of pubertal development through regulation of IGFBP-1 and sex hormone binding globulin (SHBG) [5]. In conditions of over-nutrition and obesity, the resulting increase serum concentrations of insulin, hyperinsulinemia, leads to lower levels of IGFBP-1 and reduced SHBG concentrations, thus enhancing IGF-1 and sex steroid bioavailability. Hyperandrogenism associated with PCOS may augment this situation. The converse is true in states of malnutrition, where low levels of insulin lead to increased IGFBP-1 and SHBG levels. The role of genetic factors, which may determine insulin production and obesity risk in childhood, has yet to be fully explained.


A number of other hormones interlink nutrition with reproduction, in order to prevent fertility and preserve vital bodily functions during times of famine and facilitate a return to fertility when the body is nutritionally able to cope with a pregnancy [3]. Ghrelin, secreted from the stomach, has been described as the “hunger hormone,” being released during food deprivation, causing an increase in appetite and also inhibiting GnRH secretion both directly and via an increase in secretion of corticotrophin releasing hormone (CRH). Conversely, Peptide YY, from the small bowel is secreted when nutritionally replete, suppresses appetite, and stimulates GnRH pulsatility.



Endocrine Features in the Assessment of Adolescents with Primary Amenorrhea



History


Particular features of the history are important to elicit in order to evaluate a possible cause for delayed puberty and amenorrhea. Past history of intercurrent illness, weight change, and psychological stress can all influence progression through puberty. More subtle changes in dietary restriction or sporting activities can also affect hypothalamic function. Most adolescents will have a clear view of how they compare with their peer group in terms of growth and development and may even be able to identify an age when they departed from the norm. Family histories regarding the development of a sibling can also be informative.



Examination


First, a thorough assessment of auxology should be preformed with height, weight, and pubertal staging plotted against standard reference charts. Included in this assessment is the predicted height based on parent’s stature. Short stature is a feature of several conditions presenting with primary amenorrhea including Turner’s syndrome, hypopituitarism, and CHARGE syndrome (coloboma, heart defects, atresia choanae (also known as choanal atresia), growth retardation, genital abnormalities, and ear abnormalities). Tall stature may indicate the presence of a Y-chromosome as in Swyer syndrome, or in the older age group of delayed closure of the epiphyses as a result of estrogen deficiency. Low body weight or excessive exercise is a risk factor for hypothalamic amenorrhea with overweight being more common in PCOS. There are two components to pubertal stage. The function of estrogens is determined by Tanner staging breast development. The function of androgens is based on sexual hair development. With regard to primary amenorrhea, it is useful to contrast those with delayed or absent puberty as an estrogen-deficient subgroup from those with normal breast development as being estrogen replete, accepting there is a degree of overlap between the two.


Signs of hyperandrogenism, acne, hirsutism, and alopecia are suggestive of PCOS, although biochemical testing may be required to differentiate other causes of androgen excess. The most common is late onset congenital adrenal hyperplasia. It is important to distinguish between hyperandrogenism and virilization, which also occurs with high circulating androgen levels and causes deepening of the voice, breast atrophy, increase in muscle bulk, and cliteromegaly. A rapid onset of hirsutism suggests the possibility of an androgen-secreting tumor of the ovary or adrenal gland. Hirsutism can be graded and given a Ferriman Gallwey Score by assessing the amount of hair in different parts of the body (e.g., upper lip, chin, breasts, abdomen, arms, legs) taking into account ethnic variations in the expression of hirsutism. Acanthosis nigricans (AN) is a sign of profound insulin resistance and is usually visible as hyperpigmented thickening of the skin folds of the axilla and neck; AN is associated with PCOS and obesity.


Vaginal examination is rarely required in the assessment of primary amenorrhea and should only be undertaken by an experienced adolescent gynecologist.



Endocrine Laboratory Investigation


The vast majority of cases of primary amenorrhea can be assessed with a simple initial profile composed of LH, FSH, prolactin, estradiol, and thyroid function [6,7]. A measurement of testosterone can be added in those with hyperandrogenism. In those with absent or delayed puberty, a measurement of FSH will distinguish between those with hypothalamic or pituitary conditions and those with gonadal dysgenesis (Figure 8B.1). Table 8B.2 lists reference values for endocrine investigations.





Figure 8B.1 Algorithm for the diagnosis of primary amenorrhea. Note the subgrouping based on estrogen status (breast development) and the FSH measurement. (AIS – androgen insensitivity syndrome; FSH – follicle stimulating hormone; PCOS – polycystic ovary syndrome.)




Table 8B.2 Endocrine reference ranges


Note that the values will differ between laboratories depending on the assay system being used.














































































Follicle stimulating hormone, FSH 1–10 IU/L (early follicular)
Luteinizing hormone, LH 1–10 IU/L (early follicular)
Prolactin <400 mIU/L
Thyroid stimulating hormone, TSH 0.5–4.0 IU/L
Thyroxine (T4) 50–150 nmol/L
Free T4 9–22 pmol/L
Tri-iodothyronine (T3) 1.5–3.5 nmol/L
Free T3 4.3–8.6 pmol/L
Thyroid binding globulin, TBG 7–17 mg/L
Testosterone (T) 0.5–3.5 nmol/L
Sex hormone binding globulin, SHBG 16–120 nmol/L
Free androgen index [(T × 100) ÷ SHBG] <5
Dihydrotestosterone 0.3–1 nmol/L
Androstenedione 2–10 nmol/L
Dehydroepiandrosterone sulphate 3–10 μmol/L
Cortisol
8 am 140–700 nmol/L
Midnight 0–140 nmol/L
24-hour urinary <400 nmol/24 h
Estradiol 250–500 pmol/L
Progesterone (mid-luteal) >25 nmol/L to indicate ovulation
17-hydroxyprogesterone 1–20 nmol/L
Inhibin B 5–200 pg/mL
Anti-Mullerian hormone (AMH) Values should be assessed with respect to age-related nomograms. High values are often seen in adolescents and women with polycystic ovaries.

A measurement of total testosterone (T) is considered adequate for general screening of hyperandrogenism. It is unnecessary to measure other androgens unless total T is >5 nmol/L (this will depend on the normal range of your local assay). Insulin may be elevated in overweight girls and suppresses the production of sex hormone binding globulin (SHBG) by the liver, resulting in a high free androgen index (FAI) in the presence of a normal total T. The measurement of SHBG is not always required in routine practice but is a useful marker for insulin resistance (IR).


A testosterone concentration > 5 nmol/L should be investigated to exclude androgen-secreting tumors of the ovary or adrenal gland, Cushing’s syndrome, and late-onset congenital adrenal hyperplasia (CAH). Whereas classical salt-losing CAH often presents at birth with ambiguous genitalia, partial 21-hydroxylase deficiency may present in later life, usually in the teenage years, with signs and symptoms similar to PCOS. In such cases, T may be elevated and the diagnosis confirmed by an elevated serum concentration of 17-hydroxyprogesterone (17-OHP); an abnormal ACTH-stimulation test may also be helpful (250 µg ACTH will cause an elevation of 17-OHP, usually between 65 and 470 nmol/L).


The measurement of other serum androgens is only required in cases of severe hyperandrogenism, particularly those that are rapidly progressive. Dehydroepiandrosterone sulphate (DHEAS), a product of the adrenal androgen pathway, is also raised in 10 percent of women with PCOS. The measurement of androstenedione can also be useful in some situations with the benefit, in contrast to testosterone, that it is not strongly bound to SHBG.


Raised prolactin is a rare cause of primary amenorrhea; care must be taken in the interpretation of this result because this is a volatile marker of stress that can result from examination or phlebotomy. Thyroid function is included in the work-up for primary amenorrhea even though it is also a rare cause in this age group. Anti Mullerian hormone (AMH) measurements are rarely required in this age group, where AMH reflects ovarian maturation rather than ovarian reserve for which it is useful in women older than age 30 [8].


Dynamic testing of the hypothalamus using GnRH has a degree of discriminatory power to differentiate constitutional delay of puberty from hypogonadatrophic hypogonadism. Individuals with severe gonadotropin deficiency have an impaired response to GnRH stimulation; therefore, induction of puberty can be started without delay whereas those with constitutional delay may benefit from a strategy of watchful waiting.


Karyotype is only required for those presenting with raised FSH or absent uterus on ultrasound. The identification of single gene defects that cause hypogonadatrophic hypogonadism is not routinely available, although it may become so in the future [9,10]. Fragile X permutation screening is advised for ovarian insufficiency.



Endocrine Assessment with Pelvic Ultrasound


Pelvic ultrasound is an important endocrine assessment when investigating primary amenorrhea [11]. The ultrasound examination is carried out abdominally rather than vaginally; so it is essential that a sonographer experienced in transabdominal scanning performs the examination.


The size and shape of the uterus is a guide to ambient estrogen status and are generally more informative than serum estradiol concentrations that are often at the lower limit of detection [12]. In the prepubertal uterus, the cervix is the most prominent feature with a relatively small uterine body. With progression through puberty, the fundus gradually dominates both in length and later in transverse diameter. Later in puberty, the endometrial thickness is a useful guide to estrogen status. It is important to note that in the absence of estrogen, the uterus may appear to be absent. Therefore, no pronouncement can be made regarding the presence of a uterus until a therapeutic trial of estrogen has been undertaken for at least 3 months [13].


The morphology of the ovary has to be interpreted with caution in individuals with primary amenorrhea. During puberty, the ovary passes through a multifollicular phase that can easily be confused with a polycystic morphology.


The morphology of the polycystic ovary has been defined as an ovary with 12 or more follicles measuring 2–9 mm in diameter and/or an increased ovarian volume (>10 cm3) [14], although there has been subsequent data to suggest the need for >25 follicles using the latest high-definition ultrasound scanners and young women inherently have more follicles [15].

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 18, 2020 | Posted by in GYNECOLOGY | Comments Off on Chapter 8B – Primary Amenorrhea in Pediatric and Adolescent Gynecology Practice

Full access? Get Clinical Tree

Get Clinical Tree app for offline access